Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of FF/UMEC/VI in Japanese Asthma Patients
NCT03184987Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2017
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone in asthma, sponsored by GSK. Started Jun 2017; status: completed.
02
Drugs
fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03184987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03184987.